SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-08-008675
Filing Date
2008-08-01
Accepted
2008-08-01 07:07:27
Documents
9
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y64261e10vq.htm 10-Q 465270
2 EX-4.1: FORM OF CERTIFICATE OF SHARES OF COMMON STOCK y64261exv4w1.htm EX-4.1 11993
3 EX-10.2: AMENDED AND RESTATED NON-EXCLUSIVE LICENSE AGREEMENT y64261exv10w2.htm EX-10.2 114761
4 EX-10.3: SUBSCRIPTION AGREEMENT y64261exv10w3.htm EX-10.3 28218
5 EX-12.1: STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS y64261exv12w1.htm EX-12.1 18645
6 EX-31.1: CERTIFICATION y64261exv31w1.htm EX-31.1 8653
7 EX-31.2: CERTIFICATION y64261exv31w2.htm EX-31.2 8711
8 EX-32: CERTIFICATION y64261exv32.htm EX-32 4410
9 GRAPHIC y64261y6426101.gif GRAPHIC 294415
  Complete submission text file 0000950123-08-008675.txt   1067754
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 08983221
SIC: 2834 Pharmaceutical Preparations